U.S. flag

An official website of the United States government

NM_022455.5(NSD1):c.5143G>T (p.Glu1715Ter) AND Sotos syndrome

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Sep 16, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003232701.8

Allele description

NM_022455.5(NSD1):c.5143G>T (p.Glu1715Ter)

Gene:
NSD1:nuclear receptor binding SET domain protein 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
5q35.3
Genomic location:
Preferred name:
NM_022455.5(NSD1):c.5143G>T (p.Glu1715Ter)
HGVS:
  • NC_000005.10:g.177260165G>T
  • NG_009821.1:g.132087G>T
  • NM_001365684.2:c.4270G>T
  • NM_001409301.1:c.5143G>T
  • NM_001409302.1:c.5143G>T
  • NM_001409303.1:c.5143G>T
  • NM_001409304.1:c.4723G>T
  • NM_001409305.1:c.4390G>T
  • NM_001409306.1:c.4381G>T
  • NM_001409307.1:c.4381G>T
  • NM_001409308.1:c.4270G>T
  • NM_001409309.1:c.4270G>T
  • NM_022455.5:c.5143G>TMANE SELECT
  • NM_172349.5:c.4270G>T
  • NP_001352613.1:p.Glu1446Ter
  • NP_001352613.2:p.Glu1424Ter
  • NP_001396230.1:p.Glu1715Ter
  • NP_001396231.1:p.Glu1715Ter
  • NP_001396232.1:p.Glu1715Ter
  • NP_001396233.1:p.Glu1575Ter
  • NP_001396234.1:p.Glu1464Ter
  • NP_001396235.1:p.Glu1461Ter
  • NP_001396236.1:p.Glu1461Ter
  • NP_001396237.1:p.Glu1424Ter
  • NP_001396238.1:p.Glu1424Ter
  • NP_071900.2:p.Glu1715Ter
  • NP_071900.2:p.Glu1715Ter
  • NP_758859.1:p.Glu1446Ter
  • NP_758859.2:p.Glu1424Ter
  • LRG_512t1:c.5143G>T
  • LRG_512:g.132087G>T
  • LRG_512p1:p.Glu1715Ter
  • NC_000005.9:g.176687166G>T
  • NM_001365684.1:c.4336G>T
  • NM_022455.4:c.5143G>T
  • NM_172349.3:c.4336G>T
Protein change:
E1424*
Molecular consequence:
  • NM_001365684.2:c.4270G>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001409301.1:c.5143G>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001409302.1:c.5143G>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001409303.1:c.5143G>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001409304.1:c.4723G>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001409305.1:c.4390G>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001409306.1:c.4381G>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001409307.1:c.4381G>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001409308.1:c.4270G>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001409309.1:c.4270G>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_022455.5:c.5143G>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_172349.5:c.4270G>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Sotos syndrome (SOTOS)
Synonyms:
Sotos' syndrome; Cerebral gigantism; Distinctive facial appearance, overgrowth in childhood, and learning disabilities or delayed development; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0019349; MedGen: C0175695; Orphanet: 821; OMIM: 117550

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003233118Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Sep 16, 2022)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes.

Douglas J, Hanks S, Temple IK, Davies S, Murray A, Upadhyaya M, Tomkins S, Hughes HE, Cole TR, Rahman N.

Am J Hum Genet. 2003 Jan;72(1):132-43. Epub 2002 Dec 2.

PubMed [citation]
PMID:
12464997
PMCID:
PMC378618

Mutations in NSD1 are responsible for Sotos syndrome, but are not a frequent finding in other overgrowth phenotypes.

Türkmen S, Gillessen-Kaesbach G, Meinecke P, Albrecht B, Neumann LM, Hesse V, Palanduz S, Balg S, Majewski F, Fuchs S, Zschieschang P, Greiwe M, Mennicke K, Kreuz FR, Dehmel HJ, Rodeck B, Kunze J, Tinschert S, Mundlos S, Horn D.

Eur J Hum Genet. 2003 Nov;11(11):858-65.

PubMed [citation]
PMID:
14571271
See all PubMed Citations (5)

Details of each submission

From Invitae, SCV003233118.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change creates a premature translational stop signal (p.Glu1715*) in the NSD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NSD1 are known to be pathogenic (PMID: 12464997, 14571271, 15942875, 16247291). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with NSD1-related conditions. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 16, 2024